Am. J. Respir. Crit. Care Med., Volume 157, Number 6, June 1998, 1822-1828

Exhaled Nitric Oxide in Human Lung Transplantation
A Noninvasive Marker of Acute Rejection

P. E. SILKOFF, M. CARAMORI, L. TREMBLAY, P. MCCLEAN, C. CHAPARRO, S. KESTEN, M. HUTCHEON, A. S. SLUTSKY, N. ZAMEL, and S. KESHAVJEE

Department of Respiratory Medicine, and Department of Thoracic Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; and Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois

Acute allograft rejection in animals and humans has been associated with increased nitric oxide production in the graft. Exhaled nitric oxide (ENO) measurement is a noninvasive method of assessing inflammation in airway diseases, e.g., asthma, which might be applicable to lung transplant recipients. Over 12 months, ENO of lower respiratory origin was measured in 108 lung transplant recipients with a mean time after transplant of 1,083 d. ENO (mean ± SEM; ppb) in stable patients (19.5 ± 1.1; p < 0.001) was not different from that of healthy controls (23.8 ± 3.2). ENO was significantly higher in episodes of clinical acute rejection (51.1 ± 6.3) compared with stable patients but not elevated in bronchiolitis obliterans syndrome (18.6 ± 1.5) or pulmonary infection (25.9 ± 4.0). A retrospective analysis of bronchoscopy findings and concurrent ENO (n = 99) showed that ENO did not vary according to histological findings (normal, acute rejection grade I, nonspecific inflammatory change) or with a positive BAL culture. ENO was not correlated with differential lymphocyte and neutrophil counts. ENO appears to be a valid marker of clinical acute rejection in human lung transplantation as distinct from infection or bronchiolitis obliterans. Furthermore, bronchoscopic findings in the absence of a clinical illness were not associated with a rise in ENO.

This article has been cited by other articles:

				K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF]

				P. O. Mitchell and D. M. Guidot Alcohol Ingestion by Donors Amplifies Experimental Airway Disease after Heterotopic Transplantation Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1161 - 1168. [Abstract] [Full Text] [PDF]

				F L M Ricciardolo Multiple roles of nitric oxide in the airways Thorax, February 1, 2003; 58(2): 175 - 182. [Abstract] [Full Text] [PDF]

				A. De SOYZA, A. J. FISHER, T. SMALL, and P. A. CORRIS Inhaled Corticosteroids and the Treatment of Lymphocytic Bronchiolitis Following Lung Transplantation Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1209 - 1212. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				R. A. Dweik, D. Laskowski, M. Özkan, C. Farver, and S. C. Erzurum High Levels of Exhaled Nitric Oxide (NO) and NO Synthase III Expression in Lesional Smooth Muscle in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 414 - 418. [Abstract] [Full Text]

				E. GABBAY, E. HAYDN WALTERS, B. ORSIDA, H. WHITFORD, C. WARD, T. C. KOTSIMBOS, G. I. SNELL, and T. J. WILLIAMS Post-lung Transplant Bronchiolitis Obliterans Syndrome (BOS) Is Characterized by Increased Exhaled Nitric Oxide Levels and Epithelial Inducible Nitric Oxide Synthase Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2182 - 2187. [Abstract] [Full Text]

				J. C. de JONGSTE and K. ALVING Gas Analysis Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S23 - 27. [Full Text] [PDF]

				H. DUPLAIN, C. SARTORI, M. LEPORI, M. EGLI, Y. ALLEMANN, P. NICOD, and U. SCHERRER Exhaled Nitric Oxide in High-Altitude Pulmonary Edema . Role in the Regulation of Pulmonary Vascular Tone and Evidence for a Role against Inflammation Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 221 - 224. [Abstract] [Full Text]

				S. J. Swanson, S. J. Mentzer, J. J. Reilly, R. Bueno, J. M. Lukanich, M. T. Jaklitsch, L. Kobzik, E. P. Ingenito, A. Fuhlbrigge, C. Donovan, et al. SURVEILLANCE TRANSBRONCHIAL LUNG BIOPSIES: IMPLICATION FOR SURVIVAL AFTER LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 27 - 38. [Abstract] [Full Text] [PDF]

				B. N. Mora, C. H.R. Boasquevisque, G. Uy, T. J. McCarthy, M. J. Welch, M. Boglione, and G. A. Patterson Exhaled nitric oxide correlates with experimental lung transplant rejection Ann. Thorac. Surg., January 1, 2000; 69(1): 210 - 215. [Abstract] [Full Text] [PDF]

				P. Silkoff Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2104 - 2117. [Full Text]